Delphine Stoll

955 total citations
45 papers, 698 citations indexed

About

Delphine Stoll is a scholar working on Orthopedics and Sports Medicine, Oncology and Surgery. According to data from OpenAlex, Delphine Stoll has authored 45 papers receiving a total of 698 indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Orthopedics and Sports Medicine, 21 papers in Oncology and 10 papers in Surgery. Recurrent topics in Delphine Stoll's work include Bone health and osteoporosis research (23 papers), Bone health and treatments (20 papers) and Bone and Joint Diseases (11 papers). Delphine Stoll is often cited by papers focused on Bone health and osteoporosis research (23 papers), Bone health and treatments (20 papers) and Bone and Joint Diseases (11 papers). Delphine Stoll collaborates with scholars based in Switzerland, France and Germany. Delphine Stoll's co-authors include Olivier Lamy, Bérengère Aubry‐Rozier, Elena González Rodríguez, Didier Hans, Marie Metzger, Khalil Zaman, Enisa Shevroja, Marc-Antoine Krieg, Vincent Mooser and Christophe Binnert and has published in prestigious journals such as SHILAP Revista de lepidopterología, The Journal of Clinical Endocrinology & Metabolism and Journal of Bone and Mineral Research.

In The Last Decade

Delphine Stoll

41 papers receiving 694 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Delphine Stoll Switzerland 13 517 419 243 146 41 45 698
Jane Orgee United Kingdom 7 459 0.9× 376 0.9× 109 0.4× 130 0.9× 48 1.2× 10 577
Garth Beinart United States 6 255 0.5× 200 0.5× 151 0.6× 162 1.1× 64 1.6× 9 510
M. Gallazzi Italy 10 253 0.5× 99 0.2× 144 0.6× 150 1.0× 35 0.9× 17 499
E Boling United States 5 429 0.8× 299 0.7× 237 1.0× 55 0.4× 63 1.5× 7 590
Rodolfo Argueta United States 7 222 0.4× 220 0.5× 109 0.4× 86 0.6× 24 0.6× 9 537
Annalisa Avanzati Italy 10 194 0.4× 289 0.7× 85 0.3× 56 0.4× 65 1.6× 10 466
Sabashini K. Ramchand Australia 11 155 0.3× 174 0.4× 101 0.4× 49 0.3× 20 0.5× 28 347
Marja-Kaisa Koivula Finland 12 149 0.3× 145 0.3× 122 0.5× 52 0.4× 71 1.7× 28 428
Mailze Campos Bezerra Brazil 11 161 0.3× 95 0.2× 144 0.6× 58 0.4× 50 1.2× 15 372
Avraam Avramidis Greece 9 190 0.4× 192 0.5× 142 0.6× 139 1.0× 17 0.4× 12 463

Countries citing papers authored by Delphine Stoll

Since Specialization
Citations

This map shows the geographic impact of Delphine Stoll's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Delphine Stoll with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Delphine Stoll more than expected).

Fields of papers citing papers by Delphine Stoll

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Delphine Stoll. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Delphine Stoll. The network helps show where Delphine Stoll may publish in the future.

Co-authorship network of co-authors of Delphine Stoll

This figure shows the co-authorship network connecting the top 25 collaborators of Delphine Stoll. A scholar is included among the top collaborators of Delphine Stoll based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Delphine Stoll. Delphine Stoll is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Rodríguez, Elena González, Bérengère Aubry‐Rozier, Delphine Stoll, Khalil Zaman, & Olivier Lamy. (2020). Commentary to “Denosumab for bone health in prostate and breast cancer patients receiving endocrine therapy? A systematic review and a meta-analysis of randomized trials” (Galvano et al. J Bone Oncol 2019; 18:100252). Journal of bone oncology. 22. 100294–100294. 1 indexed citations
2.
Rodríguez, Elena González, Bérengère Aubry‐Rozier, Delphine Stoll, Khalil Zaman, & Olivier Lamy. (2019). Sixty spontaneous vertebral fractures after denosumab discontinuation in 15 women with early-stage breast cancer under aromatase inhibitors. Breast Cancer Research and Treatment. 179(1). 153–159. 45 indexed citations
3.
Lamy, Olivier, Elisa Fernández-Fernández, I. Monjo, et al.. (2019). Alendronate after denosumab discontinuation in women previously exposed to bisphosphonates was not effective in preventing the risk of spontaneous multiple vertebral fractures: two case reports. Osteoporosis International. 30(5). 1111–1115. 29 indexed citations
4.
Rodríguez, Elena González, Olivier Lamy, Bérengère Aubry‐Rozier, Delphine Stoll, & Brigitte Uebelhart. (2019). [How to manage the rebound effect at denosumab discontinuation and avoid multiple vertebral fractures?]. PubMed. 15(647). 831–835. 2 indexed citations
5.
Lamy, Olivier, Delphine Stoll, Bérengère Aubry‐Rozier, & Elena González Rodríguez. (2019). Stopping Denosumab. Current Osteoporosis Reports. 17(1). 8–15. 78 indexed citations
6.
Rodríguez, Elena González, Delphine Stoll, & Olivier Lamy. (2018). Raloxifene Has No Efficacy in Reducing the High Bone Turnover and the Risk of Spontaneous Vertebral Fractures after Denosumab Discontinuation. SHILAP Revista de lepidopterología. 2018. 1–4. 19 indexed citations
7.
Rodríguez, Elena González, Olivier Lamy, Delphine Stoll, et al.. (2017). High Evening Cortisol Level Is Associated With Low TBS and Increased Prevalent Vertebral Fractures: OsteoLaus Study. The Journal of Clinical Endocrinology & Metabolism. 102(7). 2628–2636. 17 indexed citations
8.
Lamy, Olivier, Elena González Rodríguez, Delphine Stoll, & Bérengère Aubry‐Rozier. (2017). [Denosumab in clinical practice : beware before, during and after].. PubMed. 13(559). 863–866. 2 indexed citations
9.
Rodríguez, Elena González, Didier Hans, Marie Metzger, et al.. (2016). The lumbar spine age-related degenerative disease influences the BMD not the TBS: the Osteolaus cohort. Osteoporosis International. 28(3). 909–915. 56 indexed citations
10.
Aubry‐Rozier, Bérengère, Elena González Rodríguez, Delphine Stoll, & Olivier Lamy. (2015). Severe spontaneous vertebral fractures after denosumab discontinuation: three case reports. Osteoporosis International. 27(5). 1923–1925. 103 indexed citations
11.
Stoll, Delphine, et al.. (2014). Fractures atypiques du fémur: A propos de trois cas cliniques. Praxis. 103(16). 939–944.
12.
Stoll, Delphine, et al.. (2013). Changing the awareness of low vitamin D status in a rheumatology population: a pre/post-study. Swiss Medical Weekly. 143(4950). w13891–w13891. 3 indexed citations
13.
Popp, Albrecht W., et al.. (2012). Beneficial effects of PTH on spine bone mineral density (BMD) and microarchitecture (TBS) parameters in postmenopausal women with osteoporosis. A 2-year study. IRIS. 1 indexed citations
14.
Aubry‐Rozier, Bérengère, Delphine Stoll, Marc-Antoine Krieg, Olivier Lamy, & Didier Hans. (2012). What was your fracture risk evaluated by FRAX® the day before your osteoporotic fracture?. Clinical Rheumatology. 32(2). 219–223. 19 indexed citations
15.
16.
Stoll, Delphine, et al.. (2012). Diffuse nesidioblastosis with hypoglycemia mimicking an insulinoma: a case report. Journal of Medical Case Reports. 6(1). 332–332. 9 indexed citations
17.
Stoll, Delphine, Jean Dudler, Olivier Lamy, et al.. (2012). Can one or two high doses of oral vitamin D3 correct insufficiency in a non-supplemented rheumatologic population?. Osteoporosis International. 24(2). 495–500. 7 indexed citations
18.
Lamy, Olivier, Marie Metzger, Marc-Antoine Krieg, et al.. (2011). La cohorte [b]OstéoLaus[/b] : évaluation des outils de routine clinique pour la prédiction de la fracture ostéoporotique. Revue Médicale Suisse. 7(315). 2130–2136. 2 indexed citations
19.
Lamy, Olivier, et al.. (2011). [OsteoLaus: prediction of osteoporotic fractures by clinical risk factors and DXA, IVA and TBS].. PubMed. 7(315). 2130, 2132–4, 2136. 19 indexed citations
20.
Stoll, Delphine, Roger Darioli, & Nicolas Rodondi. (2009). Lipid-lowering therapies and liver enzymes. 12(9). 239–244. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jane Orgee Breakdown of academic impact, for papers by Garth Beinart Breakdown of academic impact, for papers by M. Gallazzi Breakdown of academic impact, for papers by E Boling Breakdown of academic impact, for papers by Rodolfo Argueta Breakdown of academic impact, for papers by Annalisa Avanzati Breakdown of academic impact, for papers by Sabashini K. Ramchand Breakdown of academic impact, for papers by Marja-Kaisa Koivula Breakdown of academic impact, for papers by Mailze Campos Bezerra Breakdown of academic impact, for papers by Avraam Avramidis
Rankless by CCL
2026